4
Changes in Ownership
Compass Therapeutics, Inc. Filed Acc 0001171843-22-003771
CHIEF EXECUTIVE OFFICER bought 20,215 shares at $2.47 ($49,931)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 2022-05-17 | Purchase | +20,215 | $2.47 | $49,931 | 5,173,518 | D |
| Open-market purchases · 20,215 sh · avg $2.47 · $49,931 | |||||||
Loading xslF345X03/ownership.xml…